Vertical Pharma Resources Limited
06077026
Healthy
- Going concern doubt noted in accounts (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
28/02/2025
full
Next accounts due
30/11/2026
Confirmation statement
Last: 04/01/2026
Due 18/01/2027
Industry
Officers
secretary · Since 01/02/2007
BRITISH · UNITED KINGDOM · Age 70
Also on 10 other boards
director · Since 01/02/2007
PHARMACIST
BRITISH · UNITED KINGDOM · Age 70
Also on 10 other boards
director · Since 27/09/2018
CHIEF EXECUTIVE
BRITISH · ENGLAND · Age 63
Also on 5 other boards
director · Since 27/09/2018
FINANCE DIRECTOR
BRITISH · UNITED KINGDOM · Age 48
Also on 1 other board
Persons with Significant Control
Integrated Pharmaceutical Services (Ips) Limited
Ips House, 41 Central Avenue, West Molesey, KT8 2QZ
Reg: 07112415 · England · Limited Company
Notified 17/05/2021
Charges2 outstanding
BEECHBROOK MEZZANINE II JERSEY LIMITED ACTING AS SECURITY TRUSTEE
BEECHBROOK MEZZANINE II JERSEY LIMITED AS SECURITY AGENT
CLYDESDALE BANK PUBLIC LIMITED COMPANY
CompanyRankvs 600+ SIC 21200 peers59
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to
Key FinancialsYear ending 28/02/2025
Net Worth
£1.0M
Balance sheet strength
Cash
£2.5M
Cash in the bank
Profit Before Tax
£5.5M
Bottom line earnings
Net Current Assets
£4.9M
Working capital
Current Assets
£16.6M
Current Liabilities
£11.7M
Fixed Assets
£3.9M
Debtors
£9.5M
Admin Expenses
£7.3M
Profit After Tax
£5.3M
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.42 | +£0 |
| 2024 | 1.47 | +£0 |
| 2023 | 1.28 | — |
Derived from filed accounts. Not audited figures.